← 返回

NK 细胞免疫治疗在血液系统恶性肿瘤中的进展

英文原题:Advances in natural killer cell immunotherapy for hematologic malignancies.

查看英文原题

Advances in natural killer cell immunotherapy for hematologic malignancies.

PubMed 2026/04/25(内容时间) Cancer Biol Ther Q1 · IF 5.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

自然杀伤(NK)细胞是固有免疫系统中一类独特的细胞毒性淋巴细胞。它们在抗病毒和抗肿瘤免疫中发挥着关键作用。近年来,基于NK细胞的过继性免疫治疗发展迅速。自体和单倍体相合NK细胞输注、嵌合抗原受体NK细胞以及NK细胞衔接器等创新方法不断涌现,在多种疾病的治疗中展现出良好前景。目前,NK细胞治疗的增强策略主要集中在两个关键方面:提高扩增效率和持久性,这对治疗的效力和细胞毒性效能具有积极作用。本综述系统介绍了NK细胞的功能机制及其特化的功能性亚群。本综述讨论了NK细胞治疗的进展和优化方法,并对未来的研究方向进行了展望。

展开英文摘要原文

Natural killer (NK) cells are a unique subset of cytotoxic lymphocytes within the innate immune system. They play a pivotal role in antiviral and antitumor immunity. NK cell-based adoptive immunotherapy has advanced rapidly in recent years. Innovative approaches, such as autologous/haploidentical NK cell infusion, chimeric antigen receptor NK cells, and NK cell engagers, have emerged, demonstrating promising potential in the treatment of various diseases.

Currently, enhancement strategies for NK cell therapy primarily focus on two key aspects: improving expansion efficiency and persistence, with a positive effect on the therapy's potency and cytotoxic efficacy. The present review systematically introduces the functional mechanisms of NK cells and their specialized functional subsets. This review discusses the progress and optimization methods of NK cell therapy and provides an outlook on future research directions.

论文信息

作者
Hu H、Xiong Y、Xia M、Sheng L
第一作者单位
School of Medicine, Ningbo University, Ningbo, Zhejiang Province, China.China
通讯作者单位
Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang Province, China.China
文献类型
综述
期刊
Cancer biology & therapy2026 Dec 31
原文标识
PubMed 42033215 · DOI 10.1080/15384047.2026.2658896